Collaborate Disseminate
After overcoming several manufacturing hurdles Novavax says its long-awaited COVID-19 vaccine is finally ready for mass distribution. Amid a flurry of applications being filed with regulatory agencies across the world, Indonesia has become the first co… Continue reading Novavax COVID-19 vaccine finally ready for rollout
Rochelle Walensky, director of the US Centers for Disease Control and Prevention (CDC), has formally endorsed an independent advisory panel’s recommendation to allow use of Pfizer’s COVID-19 vaccine in children aged between five and 11 years old. The e… Continue reading Pfizer COVID-19 vaccine approved for kids aged 5 to 11 in the US
A controversial dosing mistake marred last year’s announcement revealing the efficacy of AstraZeneca’s COVID-19 vaccine, but the error strangely led to better results. Now researchers from Northwestern Medicine have replicated those accidental findings… Continue reading How a COVID-19 vaccine trial error led to an unexpected discovery
After two decades of preclinical research the first phase of human trials are set to begin testing a unique preventative breast cancer vaccine that is designed to target a protein commonly expressed by triple-negative breast cancers.Continue ReadingCat… Continue reading First-of-its-kind preventative breast cancer vaccine begins human trials
Although a technology known as electroporation is very effective at delivering DNA-based vaccines, the required equipment tends to be bulky, complex and expensive. Now, however, scientists have shown that a converted barbecue lighter is capable of doin… Continue reading More-effective vaccination tech is built around a barbecue lighter
In a long-awaited decision the US Food and Drug Administration (FDA) has approved “mix and match” COVID-19 vaccine boosters, meaning your third dose does not need to be the same vaccine brand as your primary course. Alongside this announcement the FDA … Continue reading FDA approves mixing different COVID-19 vaccine boosters
Following a successful pilot study encompassing nearly one million children, the World Health Organization (WHO) is now recommending widespread use of the world’s first malaria vaccine across all sub-Saharan Africa. It is hoped the landmark vaccine can… Continue reading WHO announces “historic” roll-out of first malaria vaccine in Africa
Researchers from the University of Toledo have discovered a prospective new treatment for rheumatoid arthritis. The vaccine-based treatment strategy proved successful in preliminary animal studies and the researchers are looking to conduct more clinica… Continue reading Scientists stumble on rheumatoid arthritis vaccine with huge potential
The European Medicines Agency (EMA) has issued a broad approval for all adults over the age of 18 to be allowed a third Pfizer COVID-19 vaccine dose at least six months after a second dose. The regulator’s advice follows on from recent similar booster … Continue reading European regulator backs Pfizer COVID-19 vaccine booster for all adults
After weeks of turbulent regulatory discussions, COVID-19 vaccine boosters are finally rolling out across the United States following the final tick of approval from Rochelle Walensky, director of the Centers of Disease Control and Prevention (CDC). Th… Continue reading US finally moves forward on COVID vaccine booster plan, for Pfizer only